Product NDC: | 66288-2225 |
Proprietary Name: | Cefuroxime Sodium |
Non Proprietary Name: | Cefuroxime Sodium |
Active Ingredient(s): | 225 g/1 & nbsp; Cefuroxime Sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66288-2225 |
Labeler Name: | Samson Medical Technologies, L.L.C. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065251 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100201 |
Package NDC: | 66288-2225-1 |
Package Description: | 1 INJECTION, POWDER, FOR SOLUTION in 1 BAG (66288-2225-1) |
NDC Code | 66288-2225-1 |
Proprietary Name | Cefuroxime Sodium |
Package Description | 1 INJECTION, POWDER, FOR SOLUTION in 1 BAG (66288-2225-1) |
Product NDC | 66288-2225 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefuroxime Sodium |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100201 |
Marketing Category Name | ANDA |
Labeler Name | Samson Medical Technologies, L.L.C. |
Substance Name | CEFUROXIME SODIUM |
Strength Number | 225 |
Strength Unit | g/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |